异位ATP合成酶刺激癌细胞中细胞外囊泡的分泌
Yi-Chun Kao1, Yi-Wen Chang1, Charles P Lai2
1Department of Life Science, National Taiwan University, Taipei, 106, Taiwan.
Communications biology
|June 15, 2023
概括
癌细胞上的异位ATP合成酶 (eATP合成酶) 驱动细胞外囊泡 (EV) 分泌和免疫抑制. 在EVs上这种eATP合成酶会损害T细胞功能,突出其在瘤进展和免疫逃避中的作用.
科学领域:
- 生物化学 生物化学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 血膜上的异位ATP合成酶 (eATP合成酶) 在癌症中很普遍,是潜在的治疗点.
- 它在瘤进展和免疫调节中的功能作用尚未完全理解.
研究的目的:
- 研究eATP合成酶在癌细胞细胞外囊泡 (EV) 生产中的作用及其对免疫细胞的影响.
主要方法:
- 使用定量蛋白质组学来分析饥饿压力下的蛋白质表达.
- 测量了细胞外ATP水平,EV分泌和流入.
- 评估了Jurkat T细胞的EV吸收和随后的免疫细胞功能.
主要成果:
- 饥饿压力会增加癌细胞中eATP合成酶的表达和EV的产生.
- eATP合成酶产生细胞外ATP,通过P2X7受体和Ca2+流入刺激EV分泌.
- 携带eATP合成酶的瘤分泌的EV被T细胞吸收,抑制它们的增殖和细胞因子释放.
结论:
- eATP合成酶在促进EV分泌和调解瘤微环境中的免疫抑制方面发挥着关键作用.
- 这种机制突显了eATP合成酶作为癌症进展和免疫逃避中的关键参与者.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Overview of Secretory Vesicles
8.6K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.6K
ATP Driven Pumps III: V-type Pumps
3.8K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.8K
ATP Synthase: Mechanism
14.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


